Cancer Center

Cancer Center

Phone Numbers

Hematology / Oncology
(803) 794-7511
Radiation Oncology
(803) 791-2575
Women's Imaging
(803) 791-2486

Lung Cancer

Our Lung Cancer Program

  • Lung cancer is the second most common cancer we diagnose.
  • Two national clinical trials for treatment based on genetic testing.
  • New, less-invasive TrueBeam™ radiation technology to treat lesions.

About 1 in 14 people in the United States has been diagnosed with lung cancer.

Treating Lung Cancer

Your lung cancer treatment will depend on the type and stage of your disease. Your doctor will discuss options with you and decide what's best for your individual diagnosis.

Other Possible Treatments

Nurse Navigators

A nurse navigator will work with you through the whole treatment process. She'll help you understand your diagnosis, take care of scheduling, and coordinate with doctors to get you the answers and help you need.

Supportive Care

Our care is comprehensive, with support for your personal challenges that goes beyond the disease itself.

Just a few ways we help:

New Treatments

We’ve been on the cutting edge of treatment for 20 years, and work to bring in new techniques for our patients.

Less-Invasive Radiation
With our new TrueBeam™ technology, we can treat lung lesions with fewer risks to patients, and a shorter recovery time.

Research Trials

We offer qualifying patients access to the latest clinical trials.

Enroll in a Clinical Trial

(803) 935-8300

SUNRAY-01

Description
A Global Pivotal Placebo-Controlled Study of LY3537982 in Combination with Pembrolizumab and LY3537982 in Combination with Pembrolizumab, Pemetrexed and Platinum for the First-line treatment of Participants with KRAS G12C-Mutant Advanced Non-Small Cell Lung Cancer.

This study is being done to see how safe an investigational drug is and how well it will work to help people with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (type of lung cancer caused by a gene alteration).

Open to enrollment.

Posted By: Dr. Scott Graupner

Posted Date: 7/31/2025

Location: Lexington Medical Cancer Center

NRG-LU008

Description
NRG-LU008: Phase III Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer.

This study is testing the addition of high dose, targeted radiation to the usual treatment for locally advanced inoperable non-small cell lung cancer. 

Open to enrollment.

Posted By: Dr. Quillin Davis

Posted Date: 7/29/2024

Location: Lexington Medical Cancer Center

Alchemist - A081801

Description
Testing the addition of a type of drug called immunotherapy to the usual chemotherapy treatment for non-small cell lung cancer

Open to enrollment 

Posted By: Dr. James Wells

Posted Date: 11/23/2020

Location: Lexington Oncology